Arcadia Biosciences (RKDA) investor relations material

Company overview and business model

• Focuses on science-based consumer goods, currently offering Zola™ coconut water products with various flavors and Non-GMO certification.

• Transitioned from crop improvement and trait licensing to consumer hydration products after divesting wheat and related assets in 2024.

• Retains certain rights to previously sold crop traits and has entered into agreements to transfer or acquire specific agricultural intellectual property.

Financial performance and metrics

• Received $4.0 million from the sale of a wheat trait and $3.7 million from the sale of the Good Wheat™ brand in 2024.

• Raised approximately $2.1 million in gross proceeds from the exercise of investment options in January 2026.

• Faces recurring net losses, accumulated deficit, and insufficient resources to meet anticipated cash requirements, raising substantial doubt about ability to continue as a going concern.

Use of proceeds and capital allocation

• Will not receive proceeds from stockholder resales; proceeds from option exercises (up to $3.94 million if fully exercised) are intended for working capital and general corporate purposes.

• Management has broad discretion over use of funds, which may not enhance results or stock price.